Showing results (3361-3370 of 5,049) with videos related to

Sort By:
Pageof 505
Headache|May 20, 2025
Perceptions of health, cognition, and pain among middle-aged and older adults with migraine: A population-based cross-sectional study examining findings from the Canadian Longitudinal Study on AgingMakenna K N Jensen, Megan E O'Connell, Marla J S Mickleborough
Headache|May 20, 2025
Long-term safety and tolerability of zavegepant 10-mg nasal spray with concomitant use of anti-calcitonin gene-related peptide monoclonal antibodies or other select preventive migraine medications: Results from a phase 2/3 open-label studyGary Berman, Kathleen Mullin, Timothy Smith, et al.
Headache|May 9, 2025
Genetic migraine disorders and the response to calcitonin gene-related peptide antagonist treatmentAndrea M Kuczynski, William S Kingston
Headache|May 9, 2025
Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofenAlbert Muñoz-Vendrell, Paloma Valín-Villanueva, Raquel Tena-Cucala, et al.
Headache|November 17, 2025
Real-world effectiveness and safety of galcanezumab for the treatment of migraine: A systematic review and meta-analysisJaime Fernández-Bravo-Rodrigo, Carlos Pascual-Morena, Alicia Saz-Lara, et al.
Headache|November 14, 2025
Psychosocial factors as predictors of headache chronification: A systematic review and meta-analysis of longitudinal studiesCornel H M Tol, Corine M Visscher, Annemarie C van der Wal, et al.
Headache|November 14, 2025
Gepants for headache prevention in children and adolescents: A multicenter chart review studyLauren Shin, Olivia Mentz, Amy A Gelfand, et al.
Headache|November 13, 2025
Sex-specific differences in the relationship between AHA Life's Essential 8 factors and migraine disorders: A cross-sectional evaluation in ELSA-Brasil studyArão Belitardo de Oliveira, Itamar S Santos, Mario Fernando Prieto Peres, et al.
Headache|September 24, 2025
The acute effect of night work-related circadian misalignment on headache episodes: Results from the 1001 nights-cohortRikke Harmsen, Jakob Møller Hansen, Dagfinn Matre, et al.
Headache|October 24, 2025
A phase 1, multicenter, open-label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraineChay Ngee Lim, Gary Mo, Rajinder Bhardwaj, et al.
Pageof 505